Legend Biotech (LEGN) Construction in Progress (2019 - 2020)
Legend Biotech (LEGN) reported Construction in Progress of $33.6 million for Q4 2020, up 1082.74% on a YoY basis from $2.8 million in Q1 2020, and up 1082.74% quarter-over-quarter from $2.8 million in Q4 2019.
Legend Biotech (LEGN) Construction in Progress (2019 - 2020) Analysis & Trends
Legend Biotech has reported Construction in Progress for 2 years, with the latest figure at $33.6 million in Q4 2020.
- For the quarter ending Q4 2020, Construction in Progress rose 1082.74% year-over-year to $33.6 million; the trailing twelve-month figure through Dec 2020 stood at $33.6 million (up 1082.74% YoY), and the FY2020 full-year result was $33.6 million, up 1082.74% from the prior year.
- Construction in Progress for Q4 2020 stood at $33.6 million, up from $2.8 million in the prior quarter.
- The five-year high for Construction in Progress was $33.6 million in Q4 2020, with the low at $2.8 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 33.64 Mn |
| Dec 31, 2019 | 2.84 Mn |